Home »
Despite what you learned at school, insulin isn’t just made in the pancreas
Hear from our researcher, Dr Craig Beall, about the brain insulin production – what we’ve discovered so far, and what’s more to understand.

Viral triggers, ticks to tackle the immune system and a smart coat for insulin: Latest type 1 diabetes research
At the Type 1 Diabetes Grand Challenge, we support cutting-edge research aimed at bringing us closer to better treatments, and potentially, a cure.

What are beta cell therapies, and do they offer hope for a cure for type 1 diabetes?
Clinical trials in beta cell replacement are creating a buzz among the diabetes community. We explain what beta cell therapies are, how close they could be to becoming a potential treatment option,…

The Type 1 Diabetes Grand Challenge makes waves at DUKPC
The Type 1 Diabetes Grand Challenge took centre stage at this year’s Diabetes UK Professional Conference, uniting researchers and people affected by type 1 diabetes to share their expertise and cel…
From discovery to innovation: 103 years of insulin progress
11 January 2025 marked exactly 103 years since insulin was first given to a person with type 1 diabetes, a 14-year-old boy called Leonard Thompson. The history of insulin is one of scientific break…
New funding available to boost beta cell research in the UK
We’re launching a new funding call to address the limited availability of stem cell-derived beta cells for research purposes.

Gaining pace towards a cure – a round-up of 2024
The global quest to create better treatments and find ways to prevent and cure type 1 diabetes continued to gather pace in 2024. Here, we round-up the highlights of the year.

The Grand Challenge community – “Work differently, work collaboratively, work swiftly”
In November, we hosted our Beta Cell Therapy and Root Causes Symposium, uniting the rapidly growing Type 1 Diabetes Grand Challenge community. We hear from Mirjam Eiswirth, who lives with type 1 di…

Four innovative projects receive funding from the Type 1 Diabetes Grand Challenge
We’re investing over £2 million into four new research projects exploring creative approaches to improve beta cell therapies and tackle immune system dysfunction in type 1 diabetes.
Putting people affected by type 1 diabetes at the heart of research.
The Type 1 Diabetes Grand Challenge brings together scientists and the type 1 community to drive forward progress in areas that matter most to people with type 1.

